AQST insider buying and SEC filings, explained
Aquestive Therapeutics, Inc. · CIK 1398733
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- DE
- Fiscal year end
- Dec 31
- Former names
- MonoSol Rx, Inc.
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$1.7M
Planned sales (10b5-1)
$744K
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 15, 2026 | Planned (10b5-1) | Daniel Barber (CEO and Director) sold 25,000 shares at about $4.22 ($106K), marked as a 10b5-1 plan trade. Holdings down 4% to 627,317 shares. | SEC filing Filed Oct 16, 2026, 2:17 PM ET |
| Sep 15, 2026 | Planned (10b5-1) | Daniel Barber (CEO and Director) sold 25,000 shares at about $4.82 ($121K), marked as a 10b5-1 plan trade. Holdings down 4% to 652,317 shares. | SEC filing Filed Sep 16, 2026 |
| Sep 9, 2026 | Planned (10b5-1) | Sherry Korczynski (Chief Commercial Officer) sold 8,750 shares at $5.22 ($46K), marked as a 10b5-1 plan trade. Holdings down 4% to 235,689 shares. | SEC filing Filed Sep 11, 2026 |
| Aug 17, 2026 | Planned (10b5-1) | Daniel Barber (CEO and Director) sold 25,000 shares at about $4.29 ($107K), marked as a 10b5-1 plan trade. Holdings down 4% to 585,574 shares. | SEC filing Filed Aug 18, 2026 |
| Jul 15–16, 2026 | Planned (10b5-1) | Daniel Barber (CEO) sold 25,000 shares between Jul 15 and Jul 16 at about $4.01 ($100K), marked as a 10b5-1 plan trade. Holdings down 4% to 610,574 shares. | SEC filing Filed Jul 17, 2026 |
| Jun 23, 2026 | Planned (10b5-1) | Julie Krop (Director) sold 25,000 shares at $5.02 ($126K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Jun 24, 2026 |
| Jun 15, 2026 | Planned (10b5-1) | Daniel Barber (CEO) sold 25,000 shares at about $4.16 ($104K), marked as a 10b5-1 plan trade. Holdings down 4% to 635,574 shares. | SEC filing Filed Jun 16, 2026 |
| May 15, 2026 | Planned (10b5-1) | Daniel Barber (CEO) sold 8,257 shares at about $4.29 ($35K), marked as a 10b5-1 plan trade. Holdings down 1% to 660,574 shares. | SEC filing Filed May 18, 2026 |
| Mar 10, 2026 | Sale | Peter E. Boyd (Chief People Officer) sold 29,814 shares at about $4.17 ($124K). Holdings down 8% to 338,509 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 11, 2026 |
| Mar 10, 2026 | Sale | Daniel Barber (CEO) sold 180,677 shares at about $4.17 ($753K). Holdings down 15% to 1,004,753 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 11, 2026 |
| Mar 10, 2026 | Sale | Lori J. Braender (Chief Legal Officer) sold 40,102 shares at about $4.17 ($167K). Holdings down 8% to 442,879 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 11, 2026 |
| Mar 10, 2026 | Sale | Melina Cioffi (SVP, Regulatory Affairs) sold 25,311 shares at about $4.17 ($106K). Holdings down 8% to 274,867 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 11, 2026 |
| Mar 10, 2026 | Sale | A. Ernest Toth Jr. (CFO) sold 58,254 shares at about $4.17 ($243K). Holdings down 13% to 376,112 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 11, 2026 |
| Mar 10, 2026 | Sale | Sherry Korczynski (Chief Commercial Officer) sold 15,741 shares at about $4.17 ($66K). Holdings down 6% to 241,117 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 11, 2026 |
| Mar 10, 2026 | Sale | Cassie Jung (President / COO) sold 45,791 shares at about $4.17 ($191K). Holdings down 14% to 274,980 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 11, 2026 |
40 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
| Filed | Items | Tag | Source |
|---|---|---|---|
| Nov 3, 2026, 4:15 PM ET 8-K | Earnings released (Item 2.02) Reg FD disclosure (Item 7.01) | SEC filing |
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow AQST in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.